Epstein–Barr virus reactivation influences clonal evolution in human herpesvirus‐8‐related lymphoproliferative disorders

Background Human herpesvirus‐8 (HHV8) is a lymphotropic virus associated with different lymphoproliferative disorders, including primary effusion lymphoma (PEL), multicentric Castleman’s disease (MCD), diffuse large B‐cell lymphomas, not otherwise specified, and the rare entity known as germinotropi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Histopathology 2021-12, Vol.79 (6), p.1099-1107
Hauptverfasser: Granai, Massimo, Facchetti, Mattia, Mancini, Virginia, Goedhals, Jacqueline, Sherriff, Alicia, Mundo, Lucia, Bellan, Cristiana, Amato, Teresa, Sorrentino, Ester, Ungari, Marco, Raphael, Martine, Leoncini, Lorenzo, Facchetti, Fabio, Lazzi, Stefano
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1107
container_issue 6
container_start_page 1099
container_title Histopathology
container_volume 79
creator Granai, Massimo
Facchetti, Mattia
Mancini, Virginia
Goedhals, Jacqueline
Sherriff, Alicia
Mundo, Lucia
Bellan, Cristiana
Amato, Teresa
Sorrentino, Ester
Ungari, Marco
Raphael, Martine
Leoncini, Lorenzo
Facchetti, Fabio
Lazzi, Stefano
description Background Human herpesvirus‐8 (HHV8) is a lymphotropic virus associated with different lymphoproliferative disorders, including primary effusion lymphoma (PEL), multicentric Castleman’s disease (MCD), diffuse large B‐cell lymphomas, not otherwise specified, and the rare entity known as germinotropic lymphoproliferative disorder (GLPD). In PELs and GLPD the neoplastic cells also contain Epstein–Barr virus (EBV). In addition, occasional cases with atypical and overlapping features among these entities have been recognised, suggesting that the spectrum of the HHV8‐related lesions may not be fully characterised. Aims Here, we report two cases of lymphoproliferative disorder associated with HHV8 and EBV that further expand the spectrum of HHV8/EBV‐positive lymphoproliferative disease. Methods and results Case 1 represented HHV8/EBV‐positive extracavitary nodal PEL followed by pleural PEL. The striking characteristic of this case was the almost focal and intrasinusoidal localisation of the neoplastic cells and the association with Castleman’s disease features. In the second case, we found the entire spectrum of HHV8‐related disorders, i.e. MCD, GLPD, and PEL, coexisting in the same lymph node, underlining the variability, possible overlap and evolution among these entities. Both cases were well analysed with immunohistochemistry, determination of the EBV latency programme, and molecular analysis for clonality of immnoglobulin genes. In both patients, the disease followed an unexpected indolent course, both being still alive after 8 and 12 months, respectively. Conclusion Our findings represent further evidence of the overlap among HHV8/EBV‐positive lymphoproliferative disorders, and underline a grey zone that requires further study; they further confirm the experimental evidence that lytic EBV replication influences HHV8‐related tumorigenesis.
doi_str_mv 10.1111/his.14551
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9293042</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2564493339</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4431-6bbce7084c0231becc5ac1f604ab774b8def303dc63396868f335dace7efd50d3</originalsourceid><addsrcrecordid>eNp1kc9qFTEUh4Mo9lpd-AIy4MYups3_mdkItVRbKLhQ1yGTnPGmZCZjMjNyN9JHKPiGfRJze69FBQNJFuc7Xw75IfSS4GOS18napWPChSCP0IowKUoqRPMYrTDDTYmJrA7Qs5SuMSYVo_QpOmCcM0KoWKEf52OawA13Nz_f6RiLxcU5FRG0mdyiJxeGwg2dn2EwkArjw6B9AUvw875WrOde5xPiCOm---7mts47gtcT2MJv-nEdxhi86yBm5QKFdSlECzE9R0867RO82N-H6Mv7889nF-XVxw-XZ6dXpdlOWsq2NVDhmhtMGWnBGKEN6STmuq0q3tYWOoaZNZKxRtay7hgTVuce6KzAlh2itzvvOLc9WAPDFLVXY3S9jhsVtFN_Vwa3Vl_DohraMMxpFrzZC2L4NkOaVO-SAe_1AGFOigrJecPy8xl9_Q96HeaY_21LNZUkdU1Jpo52lIkhpQjdwzAEq22qKqeq7lPN7Ks_p38gf8eYgZMd8N152PzfpC4uP-2UvwAvF7Ph</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2597618821</pqid></control><display><type>article</type><title>Epstein–Barr virus reactivation influences clonal evolution in human herpesvirus‐8‐related lymphoproliferative disorders</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Granai, Massimo ; Facchetti, Mattia ; Mancini, Virginia ; Goedhals, Jacqueline ; Sherriff, Alicia ; Mundo, Lucia ; Bellan, Cristiana ; Amato, Teresa ; Sorrentino, Ester ; Ungari, Marco ; Raphael, Martine ; Leoncini, Lorenzo ; Facchetti, Fabio ; Lazzi, Stefano</creator><creatorcontrib>Granai, Massimo ; Facchetti, Mattia ; Mancini, Virginia ; Goedhals, Jacqueline ; Sherriff, Alicia ; Mundo, Lucia ; Bellan, Cristiana ; Amato, Teresa ; Sorrentino, Ester ; Ungari, Marco ; Raphael, Martine ; Leoncini, Lorenzo ; Facchetti, Fabio ; Lazzi, Stefano</creatorcontrib><description>Background Human herpesvirus‐8 (HHV8) is a lymphotropic virus associated with different lymphoproliferative disorders, including primary effusion lymphoma (PEL), multicentric Castleman’s disease (MCD), diffuse large B‐cell lymphomas, not otherwise specified, and the rare entity known as germinotropic lymphoproliferative disorder (GLPD). In PELs and GLPD the neoplastic cells also contain Epstein–Barr virus (EBV). In addition, occasional cases with atypical and overlapping features among these entities have been recognised, suggesting that the spectrum of the HHV8‐related lesions may not be fully characterised. Aims Here, we report two cases of lymphoproliferative disorder associated with HHV8 and EBV that further expand the spectrum of HHV8/EBV‐positive lymphoproliferative disease. Methods and results Case 1 represented HHV8/EBV‐positive extracavitary nodal PEL followed by pleural PEL. The striking characteristic of this case was the almost focal and intrasinusoidal localisation of the neoplastic cells and the association with Castleman’s disease features. In the second case, we found the entire spectrum of HHV8‐related disorders, i.e. MCD, GLPD, and PEL, coexisting in the same lymph node, underlining the variability, possible overlap and evolution among these entities. Both cases were well analysed with immunohistochemistry, determination of the EBV latency programme, and molecular analysis for clonality of immnoglobulin genes. In both patients, the disease followed an unexpected indolent course, both being still alive after 8 and 12 months, respectively. Conclusion Our findings represent further evidence of the overlap among HHV8/EBV‐positive lymphoproliferative disorders, and underline a grey zone that requires further study; they further confirm the experimental evidence that lytic EBV replication influences HHV8‐related tumorigenesis.</description><identifier>ISSN: 0309-0167</identifier><identifier>EISSN: 1365-2559</identifier><identifier>DOI: 10.1111/his.14551</identifier><identifier>PMID: 34431125</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Aged ; Castleman’s disease ; Clonal Evolution ; Coinfection - virology ; EBV ; Effusion ; Epstein-Barr virus ; Epstein-Barr Virus Infections - complications ; Epstein-Barr Virus Infections - virology ; Female ; germinotropic lymphoproliferative disorder ; Herpesviridae Infections - complications ; Herpesviridae Infections - virology ; Herpesvirus 4, Human - physiology ; Herpesvirus 8, Human ; Humans ; Immunohistochemistry ; Immunoproliferative diseases ; KSHV/HHV8 ; Latency ; Lymph nodes ; Lymphocytes ; lymphoma ; Lymphoproliferative Disorders - pathology ; Lymphoproliferative Disorders - virology ; Male ; Middle Aged ; pleural effusion ; Primary effusion lymphoma ; Short Report ; Tumorigenesis ; Virus Activation ; Viruses</subject><ispartof>Histopathology, 2021-12, Vol.79 (6), p.1099-1107</ispartof><rights>2021 The Authors. published by John Wiley &amp; Sons Ltd</rights><rights>2021 The Authors. Histopathology published by John Wiley &amp; Sons Ltd.</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4431-6bbce7084c0231becc5ac1f604ab774b8def303dc63396868f335dace7efd50d3</citedby><cites>FETCH-LOGICAL-c4431-6bbce7084c0231becc5ac1f604ab774b8def303dc63396868f335dace7efd50d3</cites><orcidid>0000-0003-2605-101X ; 0000-0002-4775-3777 ; 0000-0002-7457-300X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhis.14551$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhis.14551$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34431125$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Granai, Massimo</creatorcontrib><creatorcontrib>Facchetti, Mattia</creatorcontrib><creatorcontrib>Mancini, Virginia</creatorcontrib><creatorcontrib>Goedhals, Jacqueline</creatorcontrib><creatorcontrib>Sherriff, Alicia</creatorcontrib><creatorcontrib>Mundo, Lucia</creatorcontrib><creatorcontrib>Bellan, Cristiana</creatorcontrib><creatorcontrib>Amato, Teresa</creatorcontrib><creatorcontrib>Sorrentino, Ester</creatorcontrib><creatorcontrib>Ungari, Marco</creatorcontrib><creatorcontrib>Raphael, Martine</creatorcontrib><creatorcontrib>Leoncini, Lorenzo</creatorcontrib><creatorcontrib>Facchetti, Fabio</creatorcontrib><creatorcontrib>Lazzi, Stefano</creatorcontrib><title>Epstein–Barr virus reactivation influences clonal evolution in human herpesvirus‐8‐related lymphoproliferative disorders</title><title>Histopathology</title><addtitle>Histopathology</addtitle><description>Background Human herpesvirus‐8 (HHV8) is a lymphotropic virus associated with different lymphoproliferative disorders, including primary effusion lymphoma (PEL), multicentric Castleman’s disease (MCD), diffuse large B‐cell lymphomas, not otherwise specified, and the rare entity known as germinotropic lymphoproliferative disorder (GLPD). In PELs and GLPD the neoplastic cells also contain Epstein–Barr virus (EBV). In addition, occasional cases with atypical and overlapping features among these entities have been recognised, suggesting that the spectrum of the HHV8‐related lesions may not be fully characterised. Aims Here, we report two cases of lymphoproliferative disorder associated with HHV8 and EBV that further expand the spectrum of HHV8/EBV‐positive lymphoproliferative disease. Methods and results Case 1 represented HHV8/EBV‐positive extracavitary nodal PEL followed by pleural PEL. The striking characteristic of this case was the almost focal and intrasinusoidal localisation of the neoplastic cells and the association with Castleman’s disease features. In the second case, we found the entire spectrum of HHV8‐related disorders, i.e. MCD, GLPD, and PEL, coexisting in the same lymph node, underlining the variability, possible overlap and evolution among these entities. Both cases were well analysed with immunohistochemistry, determination of the EBV latency programme, and molecular analysis for clonality of immnoglobulin genes. In both patients, the disease followed an unexpected indolent course, both being still alive after 8 and 12 months, respectively. Conclusion Our findings represent further evidence of the overlap among HHV8/EBV‐positive lymphoproliferative disorders, and underline a grey zone that requires further study; they further confirm the experimental evidence that lytic EBV replication influences HHV8‐related tumorigenesis.</description><subject>Aged</subject><subject>Castleman’s disease</subject><subject>Clonal Evolution</subject><subject>Coinfection - virology</subject><subject>EBV</subject><subject>Effusion</subject><subject>Epstein-Barr virus</subject><subject>Epstein-Barr Virus Infections - complications</subject><subject>Epstein-Barr Virus Infections - virology</subject><subject>Female</subject><subject>germinotropic lymphoproliferative disorder</subject><subject>Herpesviridae Infections - complications</subject><subject>Herpesviridae Infections - virology</subject><subject>Herpesvirus 4, Human - physiology</subject><subject>Herpesvirus 8, Human</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Immunoproliferative diseases</subject><subject>KSHV/HHV8</subject><subject>Latency</subject><subject>Lymph nodes</subject><subject>Lymphocytes</subject><subject>lymphoma</subject><subject>Lymphoproliferative Disorders - pathology</subject><subject>Lymphoproliferative Disorders - virology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>pleural effusion</subject><subject>Primary effusion lymphoma</subject><subject>Short Report</subject><subject>Tumorigenesis</subject><subject>Virus Activation</subject><subject>Viruses</subject><issn>0309-0167</issn><issn>1365-2559</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp1kc9qFTEUh4Mo9lpd-AIy4MYups3_mdkItVRbKLhQ1yGTnPGmZCZjMjNyN9JHKPiGfRJze69FBQNJFuc7Xw75IfSS4GOS18napWPChSCP0IowKUoqRPMYrTDDTYmJrA7Qs5SuMSYVo_QpOmCcM0KoWKEf52OawA13Nz_f6RiLxcU5FRG0mdyiJxeGwg2dn2EwkArjw6B9AUvw875WrOde5xPiCOm---7mts47gtcT2MJv-nEdxhi86yBm5QKFdSlECzE9R0867RO82N-H6Mv7889nF-XVxw-XZ6dXpdlOWsq2NVDhmhtMGWnBGKEN6STmuq0q3tYWOoaZNZKxRtay7hgTVuce6KzAlh2itzvvOLc9WAPDFLVXY3S9jhsVtFN_Vwa3Vl_DohraMMxpFrzZC2L4NkOaVO-SAe_1AGFOigrJecPy8xl9_Q96HeaY_21LNZUkdU1Jpo52lIkhpQjdwzAEq22qKqeq7lPN7Ks_p38gf8eYgZMd8N152PzfpC4uP-2UvwAvF7Ph</recordid><startdate>202112</startdate><enddate>202112</enddate><creator>Granai, Massimo</creator><creator>Facchetti, Mattia</creator><creator>Mancini, Virginia</creator><creator>Goedhals, Jacqueline</creator><creator>Sherriff, Alicia</creator><creator>Mundo, Lucia</creator><creator>Bellan, Cristiana</creator><creator>Amato, Teresa</creator><creator>Sorrentino, Ester</creator><creator>Ungari, Marco</creator><creator>Raphael, Martine</creator><creator>Leoncini, Lorenzo</creator><creator>Facchetti, Fabio</creator><creator>Lazzi, Stefano</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2605-101X</orcidid><orcidid>https://orcid.org/0000-0002-4775-3777</orcidid><orcidid>https://orcid.org/0000-0002-7457-300X</orcidid></search><sort><creationdate>202112</creationdate><title>Epstein–Barr virus reactivation influences clonal evolution in human herpesvirus‐8‐related lymphoproliferative disorders</title><author>Granai, Massimo ; Facchetti, Mattia ; Mancini, Virginia ; Goedhals, Jacqueline ; Sherriff, Alicia ; Mundo, Lucia ; Bellan, Cristiana ; Amato, Teresa ; Sorrentino, Ester ; Ungari, Marco ; Raphael, Martine ; Leoncini, Lorenzo ; Facchetti, Fabio ; Lazzi, Stefano</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4431-6bbce7084c0231becc5ac1f604ab774b8def303dc63396868f335dace7efd50d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Castleman’s disease</topic><topic>Clonal Evolution</topic><topic>Coinfection - virology</topic><topic>EBV</topic><topic>Effusion</topic><topic>Epstein-Barr virus</topic><topic>Epstein-Barr Virus Infections - complications</topic><topic>Epstein-Barr Virus Infections - virology</topic><topic>Female</topic><topic>germinotropic lymphoproliferative disorder</topic><topic>Herpesviridae Infections - complications</topic><topic>Herpesviridae Infections - virology</topic><topic>Herpesvirus 4, Human - physiology</topic><topic>Herpesvirus 8, Human</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Immunoproliferative diseases</topic><topic>KSHV/HHV8</topic><topic>Latency</topic><topic>Lymph nodes</topic><topic>Lymphocytes</topic><topic>lymphoma</topic><topic>Lymphoproliferative Disorders - pathology</topic><topic>Lymphoproliferative Disorders - virology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>pleural effusion</topic><topic>Primary effusion lymphoma</topic><topic>Short Report</topic><topic>Tumorigenesis</topic><topic>Virus Activation</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Granai, Massimo</creatorcontrib><creatorcontrib>Facchetti, Mattia</creatorcontrib><creatorcontrib>Mancini, Virginia</creatorcontrib><creatorcontrib>Goedhals, Jacqueline</creatorcontrib><creatorcontrib>Sherriff, Alicia</creatorcontrib><creatorcontrib>Mundo, Lucia</creatorcontrib><creatorcontrib>Bellan, Cristiana</creatorcontrib><creatorcontrib>Amato, Teresa</creatorcontrib><creatorcontrib>Sorrentino, Ester</creatorcontrib><creatorcontrib>Ungari, Marco</creatorcontrib><creatorcontrib>Raphael, Martine</creatorcontrib><creatorcontrib>Leoncini, Lorenzo</creatorcontrib><creatorcontrib>Facchetti, Fabio</creatorcontrib><creatorcontrib>Lazzi, Stefano</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Histopathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Granai, Massimo</au><au>Facchetti, Mattia</au><au>Mancini, Virginia</au><au>Goedhals, Jacqueline</au><au>Sherriff, Alicia</au><au>Mundo, Lucia</au><au>Bellan, Cristiana</au><au>Amato, Teresa</au><au>Sorrentino, Ester</au><au>Ungari, Marco</au><au>Raphael, Martine</au><au>Leoncini, Lorenzo</au><au>Facchetti, Fabio</au><au>Lazzi, Stefano</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epstein–Barr virus reactivation influences clonal evolution in human herpesvirus‐8‐related lymphoproliferative disorders</atitle><jtitle>Histopathology</jtitle><addtitle>Histopathology</addtitle><date>2021-12</date><risdate>2021</risdate><volume>79</volume><issue>6</issue><spage>1099</spage><epage>1107</epage><pages>1099-1107</pages><issn>0309-0167</issn><eissn>1365-2559</eissn><abstract>Background Human herpesvirus‐8 (HHV8) is a lymphotropic virus associated with different lymphoproliferative disorders, including primary effusion lymphoma (PEL), multicentric Castleman’s disease (MCD), diffuse large B‐cell lymphomas, not otherwise specified, and the rare entity known as germinotropic lymphoproliferative disorder (GLPD). In PELs and GLPD the neoplastic cells also contain Epstein–Barr virus (EBV). In addition, occasional cases with atypical and overlapping features among these entities have been recognised, suggesting that the spectrum of the HHV8‐related lesions may not be fully characterised. Aims Here, we report two cases of lymphoproliferative disorder associated with HHV8 and EBV that further expand the spectrum of HHV8/EBV‐positive lymphoproliferative disease. Methods and results Case 1 represented HHV8/EBV‐positive extracavitary nodal PEL followed by pleural PEL. The striking characteristic of this case was the almost focal and intrasinusoidal localisation of the neoplastic cells and the association with Castleman’s disease features. In the second case, we found the entire spectrum of HHV8‐related disorders, i.e. MCD, GLPD, and PEL, coexisting in the same lymph node, underlining the variability, possible overlap and evolution among these entities. Both cases were well analysed with immunohistochemistry, determination of the EBV latency programme, and molecular analysis for clonality of immnoglobulin genes. In both patients, the disease followed an unexpected indolent course, both being still alive after 8 and 12 months, respectively. Conclusion Our findings represent further evidence of the overlap among HHV8/EBV‐positive lymphoproliferative disorders, and underline a grey zone that requires further study; they further confirm the experimental evidence that lytic EBV replication influences HHV8‐related tumorigenesis.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34431125</pmid><doi>10.1111/his.14551</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-2605-101X</orcidid><orcidid>https://orcid.org/0000-0002-4775-3777</orcidid><orcidid>https://orcid.org/0000-0002-7457-300X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0309-0167
ispartof Histopathology, 2021-12, Vol.79 (6), p.1099-1107
issn 0309-0167
1365-2559
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9293042
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Aged
Castleman’s disease
Clonal Evolution
Coinfection - virology
EBV
Effusion
Epstein-Barr virus
Epstein-Barr Virus Infections - complications
Epstein-Barr Virus Infections - virology
Female
germinotropic lymphoproliferative disorder
Herpesviridae Infections - complications
Herpesviridae Infections - virology
Herpesvirus 4, Human - physiology
Herpesvirus 8, Human
Humans
Immunohistochemistry
Immunoproliferative diseases
KSHV/HHV8
Latency
Lymph nodes
Lymphocytes
lymphoma
Lymphoproliferative Disorders - pathology
Lymphoproliferative Disorders - virology
Male
Middle Aged
pleural effusion
Primary effusion lymphoma
Short Report
Tumorigenesis
Virus Activation
Viruses
title Epstein–Barr virus reactivation influences clonal evolution in human herpesvirus‐8‐related lymphoproliferative disorders
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T10%3A41%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epstein%E2%80%93Barr%20virus%20reactivation%20influences%20clonal%20evolution%20in%20human%20herpesvirus%E2%80%908%E2%80%90related%20lymphoproliferative%20disorders&rft.jtitle=Histopathology&rft.au=Granai,%20Massimo&rft.date=2021-12&rft.volume=79&rft.issue=6&rft.spage=1099&rft.epage=1107&rft.pages=1099-1107&rft.issn=0309-0167&rft.eissn=1365-2559&rft_id=info:doi/10.1111/his.14551&rft_dat=%3Cproquest_pubme%3E2564493339%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2597618821&rft_id=info:pmid/34431125&rfr_iscdi=true